292 related articles for article (PubMed ID: 10085153)
1. High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer.
Perrella MA; Pellacani A; Wiesel P; Chin MT; Foster LC; Ibanez M; Hsieh CM; Reeves R; Yet SF; Lee ME
J Biol Chem; 1999 Mar; 274(13):9045-52. PubMed ID: 10085153
[TBL] [Abstract][Full Text] [Related]
2. Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein beta and nuclear factor-kappaB in hepatocytes.
Sakitani K; Nishizawa M; Inoue K; Masu Y; Okumura T; Ito S
Genes Cells; 1998 May; 3(5):321-30. PubMed ID: 9685183
[TBL] [Abstract][Full Text] [Related]
3. Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase.
Pellacani A; Chin MT; Wiesel P; Ibanez M; Patel A; Yet SF; Hsieh CM; Paulauskis JD; Reeves R; Lee ME; Perrella MA
J Biol Chem; 1999 Jan; 274(3):1525-32. PubMed ID: 9880529
[TBL] [Abstract][Full Text] [Related]
4. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene.
Taylor BS; de Vera ME; Ganster RW; Wang Q; Shapiro RA; Morris SM; Billiar TR; Geller DA
J Biol Chem; 1998 Jun; 273(24):15148-56. PubMed ID: 9614127
[TBL] [Abstract][Full Text] [Related]
5. A reverse nuclear factor-kappaB element in the rat type II nitric oxide synthase promoter mediates the induction by interleukin-1beta and interferon-gamma in rat aortic smooth muscle cells.
Teng X; Zhang H; Snead C; Catravas JD
Gen Pharmacol; 2000 Jan; 34(1):9-16. PubMed ID: 10793263
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-beta1.
Pellacani A; Wiesel P; Razavi S; Vasilj V; Feinberg MW; Chin MT; Reeves R; Perrella MA
J Biol Chem; 2001 Jan; 276(2):1653-9. PubMed ID: 11056164
[TBL] [Abstract][Full Text] [Related]
7. An octamer motif is required for activation of the inducible nitric oxide synthase promoter in pancreatic beta-cells.
Darville MI; Terryn S; Eizirik DL
Endocrinology; 2004 Mar; 145(3):1130-6. PubMed ID: 14630716
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells.
Eberhardt W; Plüss C; Hummel R; Pfeilschifter J
J Immunol; 1998 May; 160(10):4961-9. PubMed ID: 9590244
[TBL] [Abstract][Full Text] [Related]
9. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
Yu Z; Zhang W; Kone BC
Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the human iNOS gene by IL-1beta in endothelial cells.
Kolyada AY; Madias NE
Mol Med; 2001 May; 7(5):329-43. PubMed ID: 11474579
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia induces high-mobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium.
Ji YS; Xu Q; Schmedtje JF
Circ Res; 1998 Aug; 83(3):295-304. PubMed ID: 9710122
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation.
Majano P; Lara-Pezzi E; López-Cabrera M; Apolinario A; Moreno-Otero R; García-Monzón C
Hepatology; 2001 Dec; 34(6):1218-24. PubMed ID: 11732012
[TBL] [Abstract][Full Text] [Related]
13. Octamer motif is required for the NF-kappaB-mediated induction of the inducible nitric oxide synthase gene expression in RAW 264.7 macrophages.
Kim YM; Ko CB; Park YP; Kim YJ; Paik SG
Mol Cells; 1999 Feb; 9(1):99-109. PubMed ID: 10102579
[TBL] [Abstract][Full Text] [Related]
14. Suppression of interleukin-1beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-beta1 in vascular smooth muscle cells. Evidence for mechanisms other than NF-kappaB.
Perrella MA; Patterson C; Tan L; Yet SF; Hsieh CM; Yoshizumi M; Lee ME
J Biol Chem; 1996 Jun; 271(23):13776-80. PubMed ID: 8662809
[TBL] [Abstract][Full Text] [Related]
15. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
Darville MI; Eizirik DL
Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
[TBL] [Abstract][Full Text] [Related]
16. Distamycin prolongs E-selectin expression by interacting with a specific NF-kappaB-HMG-I(Y) binding site in the promoter.
Ghersa P; Whelan J; Cambet Y; DeLamarter JF; Hooft van Huijsduijnen R
Nucleic Acids Res; 1997 Jan; 25(2):339-46. PubMed ID: 9016563
[TBL] [Abstract][Full Text] [Related]
17. Cooperativity between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter.
Lewis H; Kaszubska W; DeLamarter JF; Whelan J
Mol Cell Biol; 1994 Sep; 14(9):5701-9. PubMed ID: 7520524
[TBL] [Abstract][Full Text] [Related]
18. Vicinal dithiol-binding agent, phenylarsine oxide, inhibits inducible nitric-oxide synthase gene expression at a step of nuclear factor-kappaB DNA binding in hepatocytes.
Oda M; Sakitani K; Kaibori M; Inoue T; Kamiyama Y; Okumura T
J Biol Chem; 2000 Feb; 275(6):4369-73. PubMed ID: 10660607
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells.
Zhang H; Chen X; Teng X; Snead C; Catravas JD
Biochem Pharmacol; 1998 Jun; 55(11):1873-80. PubMed ID: 9714306
[TBL] [Abstract][Full Text] [Related]
20. Non-NF-kappaB elements are required for full induction of the rat type II nitric oxide synthase in vascular smooth muscle cells.
Zhang H; Teng X; Snead C; Catravas JD
Br J Pharmacol; 2000 May; 130(2):270-8. PubMed ID: 10807663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
